StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Citi Resumes GlaxoSmithKline (GSK:LN) (GSK) at Neutral
September 3, 2019 3:28 AM
Citi analyst Andrew Baum resumes coverage on GlaxoSmithKline (GSK:LN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Intl Ratings
New Coverage
Next Articles
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBp1,645 at Deutsche Bank
September 2, 2019 8:44 AM